Mount Sinai Hospital

Mount Sinai Hospital was paid $91.91M by Medicaid between Jan 2018 and Dec 2024, across 631 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 17% of everything it billed.

33Billing provider infoMOUNT SINAI HOSPITAL
LONG ISLAND CITY, NY 11102

33aNPI1245248939assigned 08/04/2006

33bProvider typeGeneral Acute Care Hospital

28Total paid$91.91M

24GClaims2,126,607

24DCodes billed631

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in New York

Rank by total paid#15 of 231

Median peer was paid$561K

This provider vs. median164×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	9,080	$289K
2019	127,299	$5.31M
2020	320,707	$14.23M
2021	453,694	$19.13M
2022	440,982	$18.82M
2023	453,597	$19.18M
2024incomplete	321,248	$14.96M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0463	Hospital outpatient clinic visit for assessment and management of a patient	17%	134,025	109,419	$15.86M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	9.0%	54,300	50,771	$8.30M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	6.3%	38,233	36,266	$5.79M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	4.9%	32,667	30,917	$4.55M
Q5104	Injection, infliximab-abda, biosimilar, (renflexis), 10 mg	4.6%	1,579	1,494	$4.27M
96361	Intravenous infusion, hydration; each additional hour	3.0%	17,381	15,342	$2.73M
G0378	Hospital observation service, per hour	2.6%	2,335	2,264	$2.39M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	2.4%	9,954	7,976	$2.23M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	2.0%	8,776	6,205	$1.88M
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	2.0%	34,733	32,978	$1.86M
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	2.0%	18,623	16,993	$1.82M
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	1.8%	16,611	14,008	$1.69M

619 more codes

J3380	Injection, vedolizumab, intravenous, 1 mg	1.6%	261	$1.44M
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	1.5%	1,706	$1.37M
70450	Computed tomography, head or brain; without contrast material	1.5%	8,010	$1.36M
90834	Psychotherapy session, about 45 minutes	1.5%	7,789	$1.33M
93458		1.4%	661	$1.33M
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	1.4%	20,867	$1.32M
74177	Computed tomography, abdomen and pelvis; with contrast material	1.3%	6,856	$1.21M
J7170	Injection, emicizumab-kxwh, 0.5 mg	1.3%	14	$1.19M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	1.3%	3,696	$1.15M
80053	Comprehensive metabolic panel	1.1%	100,371	$986K
93975		<1%	2,524	$910K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	2,450	$871K
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	5,127	$808K
96375	Therapeutic injection; each additional sequential IV push	<1%	19,333	$785K
90832	Psychotherapy session, about 30 minutes	<1%	4,930	$679K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	11,605	$583K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	3,634	$570K
96367		<1%	2,634	$560K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	4,932	$546K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	24,361	$504K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	803	$477K
47562		<1%	199	$461K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	2,450	$456K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	4,908	$452K
71275	Computed tomographic angiography, chest, with contrast material	<1%	2,394	$445K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	24,669	$435K
93970		<1%	1,441	$405K
86900		<1%	16,672	$354K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	453	$331K
93976		<1%	1,235	$329K
80048	Basic metabolic panel (calcium, ionized)	<1%	27,670	$312K
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	707	$310K
90935	Hemodialysis procedure with single evaluation by a physician	<1%	1,958	$305K
12001		<1%	923	$300K
G0008	Administration of influenza virus vaccine	<1%	7,704	$294K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	2,995	$272K
96402		<1%	967	$262K
36415	Collection of venous blood by venipuncture	<1%	83,834	$261K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	38,627	$257K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	3,003	$245K
90836		<1%	2,254	$243K
80061	Lipid panel	<1%	22,985	$234K
99204	Doctor's office visit, new patient (more involved)	<1%	1,537	$218K
12011		<1%	633	$211K
J1561	Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg	<1%	70	$210K
36000		<1%	10,825	$206K
J1439	Injection, ferric carboxymaltose, 1 mg	<1%	297	$203K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	3,704	$197K
96415		<1%	3,724	$190K
96401		<1%	836	$179K
99203	Doctor's office visit, new patient (routine)	<1%	1,401	$169K
97162		<1%	1,755	$168K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	1,308	$163K
99215	Doctor's office visit, returning patient (complex)	<1%	1,511	$162K
76641		<1%	1,905	$155K
86901		<1%	14,584	$150K
70496		<1%	871	$150K
36430		<1%	722	$148K
86850		<1%	16,522	$145K
87631		<1%	3,566	$141K
76770		<1%	937	$138K
87428		<1%	5,930	$135K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	13,039	$133K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	5,947	$133K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	1,456	$126K
71046	Radiologic examination, chest; 2 views	<1%	16,090	$125K
77063	Screening digital breast tomosynthesis, bilateral	<1%	4,796	$124K
83880		<1%	8,648	$124K
53450		<1%	98	$120K
90853	Group psychotherapy (other than of a multiple-family group)	<1%	1,574	$114K
75574		<1%	669	$110K
76819	Fetal biophysical profile; without non-stress testing	<1%	970	$110K
83036	Hemoglobin; glycosylated (A1C)	<1%	22,453	$100K
90686		<1%	8,801	$98K
88307		<1%	883	$96K
88342		<1%	2,329	$95K
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	<1%	1,682	$95K
93971		<1%	1,640	$94K
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	894	$92K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	10,497	$90K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	1,589	$90K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	16,525	$89K
76937		<1%	580	$86K
93017		<1%	2,261	$86K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	7,946	$85K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	95,710	$84K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	115	$82K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	2,434	$79K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	3,118	$79K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	432	$77K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	11,931	$77K
88304		<1%	2,929	$75K
90670		<1%	2,196	$74K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	3,188	$73K
86780		<1%	7,459	$72K
81025		<1%	34,947	$70K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	1,650	$70K
76830	Ultrasound, transvaginal	<1%	2,103	$70K
Q0138	Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)	<1%	261	$69K
90677		<1%	634	$68K
0002A		<1%	1,816	$67K
90833	Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on)	<1%	1,290	$66K
86480		<1%	3,646	$64K
10060		<1%	262	$63K
87536		<1%	2,097	$63K
G0009	Administration of pneumococcal vaccine	<1%	1,831	$63K
90671		<1%	216	$62K
P9040	Red blood cells, leukocytes reduced, irradiated, each unit	<1%	225	$62K
0001A		<1%	1,754	$61K
76801		<1%	610	$60K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	1,813	$59K
88184		<1%	627	$59K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	373	$53K
70486		<1%	943	$50K
90846	Family psychotherapy without the patient present, 50 minutes	<1%	380	$50K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	1,986	$49K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	6,491	$49K
77066	Tomosynthesis, mammo	<1%	441	$49K
87799		<1%	2,027	$49K
92012	Ophthalmological services: medical examination and evaluation, intermediate, established patient	<1%	380	$48K
91200		<1%	1,011	$46K
97165		<1%	508	$46K
76536		<1%	732	$46K
70491		<1%	370	$45K
80197		<1%	5,550	$44K
76642		<1%	639	$44K
J2785	Injection, regadenoson, 0.1 mg	<1%	911	$42K
72125	Computed tomography, cervical spine; without contrast material	<1%	1,561	$42K
C1889	Implantable/insertable device, not otherwise classified	<1%	1,419	$42K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	4,234	$42K
80050	General health panel	<1%	2,292	$41K
85610		<1%	25,132	$41K
86769		<1%	1,497	$41K
38222		<1%	26	$41K
J1756	Injection, iron sucrose, 1 mg	<1%	1,115	$40K
82728		<1%	11,847	$40K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	11,011	$40K
87497		<1%	2,299	$39K
G0123	Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision	<1%	2,147	$39K
90715		<1%	3,646	$38K
96368		<1%	493	$38K
92014	Ophthalmological services: medical examination and evaluation, comprehensive, established patient	<1%	311	$38K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	1,036	$38K
90792	Psychiatric diagnostic evaluation with medical services	<1%	193	$37K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	93	$36K
Q5107	Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg	<1%	18	$36K
71250		<1%	372	$35K
80076		<1%	5,888	$35K
59025	Fetal non-stress test	<1%	207	$35K
66984	Extracapsular cataract removal with insertion of intraocular lens prosthesis	<1%	28	$34K
86923		<1%	1,504	$34K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	356	$34K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	37,891	$34K
84443	Thyroid stimulating hormone (TSH)	<1%	12,779	$33K
99443		<1%	654	$32K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	1,001	$31K
88185		<1%	740	$31K
82105		<1%	4,054	$30K
G0010	Administration of hepatitis b vaccine	<1%	774	$29K
Q5111	Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg	<1%	21	$28K
99442		<1%	652	$28K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	243	$28K
87522	Neg quan hep c or qual rna	<1%	1,976	$27K
83735		<1%	18,150	$26K
77065	Tomosynthesis, mammo	<1%	303	$26K
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	<1%	252	$25K
87517		<1%	1,539	$25K
83970		<1%	1,468	$25K
J0897	Injection, denosumab, 1 mg	<1%	14	$24K
86803		<1%	9,982	$23K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	1,597	$23K
Q9957	Injection, perflutren lipid microspheres, per ml	<1%	1,148	$23K
Q0091	Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory	<1%	1,266	$23K
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	<1%	490	$23K
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	<1%	58	$23K
82977		<1%	14,167	$23K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	2,096	$22K
82784		<1%	7,599	$22K
85027		<1%	15,677	$21K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	79	$21K
88341		<1%	742	$21K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	622	$20K
86706		<1%	7,471	$20K
82607		<1%	5,438	$19K
C1760	Closure device, vascular (implantable/insertable)	<1%	547	$19K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	155	$19K
73562		<1%	1,783	$19K
90732		<1%	306	$18K
87507		<1%	185	$18K
72100		<1%	1,192	$18K
72131		<1%	241	$18K
84439		<1%	6,953	$18K
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	<1%	188	$18K
96376		<1%	3,294	$17K
83540		<1%	11,378	$17K
73030		<1%	2,112	$17K
87340		<1%	8,643	$16K
83550		<1%	10,075	$16K
J1453	Injection, fosaprepitant, 1 mg	<1%	440	$16K
0003A		<1%	397	$16K
46260		<1%	12	$16K
82248		<1%	16,708	$15K
94060		<1%	61	$15K
97116		<1%	528	$15K
J0882	Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis)	<1%	87	$14K
91320		<1%	192	$14K
84100		<1%	12,190	$14K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	26	$13K
86704		<1%	4,540	$13K
73630		<1%	2,901	$13K
73560		<1%	1,848	$12K
99205	Prolong outpt/office vis	<1%	84	$12K
96417		<1%	1,596	$12K
90674		<1%	912	$12K
0224U		<1%	331	$12K
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established)	<1%	1,132	$12K
99441		<1%	267	$12K
82043		<1%	5,959	$11K
83615		<1%	12,957	$11K
95249		<1%	207	$11K
94375		<1%	325	$11K
0124A		<1%	276	$11K
74174		<1%	102	$11K
83655		<1%	1,875	$11K
82378		<1%	2,425	$10K
82570		<1%	7,213	$10K
0004A		<1%	242	$10K
C1769	Guide wire	<1%	2,371	$10K
73610		<1%	2,381	$10K
99385		<1%	91	$10K
88112		<1%	301	$10K
83883		<1%	4,498	$10K
71045	Radiologic examination, chest; single view	<1%	4,836	$10K
90472	Immunization administration, each additional vaccine (list separately)	<1%	1,749	$10K
90694		<1%	450	$10K
84153		<1%	1,578	$10K
73502		<1%	1,037	$10K
70498		<1%	434	$10K
86592		<1%	2,854	$9K
82803		<1%	1,228	$9K
85730		<1%	18,350	$9K
86334		<1%	1,780	$9K
90746		<1%	266	$8K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	46	$8K
84403		<1%	1,491	$8K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	87	$8K
73130		<1%	2,470	$8K
93320		<1%	377	$8K
29540		<1%	41	$8K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	1,216	$7K
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	<1%	277	$7K
86708		<1%	1,364	$7K
81003		<1%	22,718	$7K
97802		<1%	867	$7K
86665		<1%	453	$7K
J3490	Unclassified drugs	<1%	2,726	$7K
86301		<1%	1,055	$7K
84702		<1%	7,928	$7K
92551		<1%	186	$6K
84466		<1%	1,236	$6K
90791	Psychiatric diagnostic evaluation	<1%	33	$6K
87086	Culture, bacterial; quantitative colony count, urine	<1%	11,518	$6K
96127		<1%	601	$6K
86870		<1%	50	$6K
83520		<1%	2,050	$6K
87901		<1%	45	$6K
90480		<1%	157	$6K
84484		<1%	22,563	$6K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	7,710	$6K
99173		<1%	163	$6K
88142		<1%	309	$6K
84165		<1%	2,886	$6K
83690		<1%	19,300	$6K
0042T		<1%	116	$6K
86787		<1%	1,766	$6K
97010		<1%	546	$6K
80051		<1%	760	$5K
86361		<1%	1,426	$5K
11721		<1%	343	$5K
87899		<1%	455	$5K
C1780	Lens, intraocular (new technology)	<1%	176	$5K
97161		<1%	51	$5K
90847	Family psychotherapy with the patient present, 50 minutes	<1%	18	$5K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	46	$5K
73110		<1%	1,492	$5K
84550		<1%	7,998	$5K
97535	Self-care/home management training, each 15 minutes	<1%	96	$5K
A9575	Injection, gadoterate meglumine, 0.1 ml	<1%	426	$5K
82670		<1%	1,047	$5K
83001		<1%	1,185	$5K
J2704	Injection, propofol, 10 mg	<1%	10,054	$5K
86762		<1%	1,447	$4K
12002		<1%	12	$4K
76870		<1%	379	$4K
G0121	Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk	<1%	12	$4K
99051		<1%	576	$4K
J8540	Dexamethasone, oral, 0.25 mg	<1%	1,844	$4K
82746		<1%	1,341	$4K
G0446	Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes	<1%	216	$4K
82150		<1%	3,308	$4K
93242		<1%	88	$4K
82533		<1%	1,264	$4K
84146		<1%	763	$4K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	824	$4K
90656		<1%	542	$4K
86765		<1%	1,470	$4K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	3,491	$4K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	16,302	$4K
51702		<1%	15	$4K
76857		<1%	124	$4K
99386		<1%	36	$4K
87480		<1%	1,269	$4K
93308		<1%	13	$4K
81001		<1%	14,332	$4K
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	27	$4K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	4,978	$3K
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	7,477	$3K
83002		<1%	1,009	$3K
86644		<1%	437	$3K
J2916	Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg	<1%	211	$3K
J1050	Injection, medroxyprogesterone acetate, 1 mg	<1%	481	$3K
73700		<1%	26	$3K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	42	$3K
86593		<1%	926	$3K
82947		<1%	2,167	$3K
J1170	Injection, hydromorphone, up to 4 mg	<1%	2,137	$3K
C1887	Catheter, guiding (may include infusion/perfusion capability)	<1%	1,201	$3K
74455		<1%	13	$3K
86039		<1%	1,316	$3K
84156		<1%	3,388	$3K
73564		<1%	170	$3K
C1874	Stent, coated/covered, with delivery system	<1%	24	$3K
T1013	Sign language or oral interpretive services, per 15 minutes	<1%	185	$3K
86141		<1%	1,615	$3K
90744		<1%	343	$3K
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	2,594	$3K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	2,992	$3K
87510		<1%	1,033	$3K
90739		<1%	53	$3K
97014		<1%	162	$3K
J1720	Injection, hydrocortisone sodium succinate, up to 100 mg	<1%	226	$3K
86300		<1%	422	$3K
86255		<1%	552	$3K
82232		<1%	742	$3K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	7,991	$3K
82950		<1%	572	$2K
72141		<1%	13	$2K
85045		<1%	4,582	$2K
73080		<1%	666	$2K
88313		<1%	881	$2K
86376		<1%	704	$2K
97803		<1%	229	$2K
80069		<1%	2,451	$2K
84270		<1%	626	$2K
83021		<1%	1,587	$2K
74018		<1%	304	$2K
36591		<1%	109	$2K
82550		<1%	3,859	$2K
88237		<1%	25	$2K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	10,575	$2K
86695		<1%	262	$2K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	1,449	$2K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	4,157	$2K
82565		<1%	3,346	$2K
93325		<1%	391	$2K
90662		<1%	84	$2K
74150		<1%	41	$2K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	29	$2K
87590		<1%	833	$2K
0072A		<1%	64	$2K
81002		<1%	16,592	$2K
92250		<1%	211	$2K
85651		<1%	7,226	$2K
36600		<1%	96	$2K
76775		<1%	27	$2K
84480		<1%	676	$2K
J3370	Injection, vancomycin hcl, 500 mg	<1%	939	$2K
0064A		<1%	37	$2K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	2,518	$2K
G0447	Face-to-face behavioral counseling for obesity, 15 minutes	<1%	24	$2K
J0690	Injection, cefazolin sodium, 500 mg	<1%	5,285	$2K
86140		<1%	6,965	$2K
82465		<1%	460	$2K
82962		<1%	12,704	$2K
72170		<1%	197	$2K
92083		<1%	221	$2K
86735		<1%	466	$2K
0071A		<1%	76	$1K
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	205	$1K
73590		<1%	861	$1K
88311		<1%	379	$1K
92557		<1%	26	$1K
83010		<1%	662	$1K
86705		<1%	261	$1K
87186		<1%	2,614	$1K
86360		<1%	171	$1K
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	3,279	$1K
77080		<1%	38	$1K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	13,499	$1K
84460		<1%	4,294	$1K
93799		<1%	137	$1K
0054A		<1%	28	$1K
87040		<1%	4,198	$1K
84402		<1%	285	$1K
85378		<1%	4,806	$1K
90680		<1%	487	$1K
90461		<1%	1,980	$1K
90460	Immunization administration through 18 years of age via any route, first or only component	<1%	3,000	$1K
C1781	Mesh (implantable)	<1%	24	$1K
96411		<1%	101	$1K
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	2,211	$1K
73090		<1%	695	$1K
S0028	Injection, famotidine, 20 mg	<1%	3,388	$1K
82247		<1%	3,729	$1K
90474		<1%	382	$945.14
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	2,078	$916.39
80055		<1%	118	$908.61
93225		<1%	12	$903.79
87077		<1%	1,888	$862.05
85384		<1%	1,085	$811.73
84075		<1%	3,375	$808.31
94726		<1%	13	$788.41
84450		<1%	2,800	$786.40
J2501	Injection, paricalcitol, 1 mcg	<1%	221	$775.99
J3475	Injection, magnesium sulfate, per 500 mg	<1%	752	$774.90
87070		<1%	2,913	$769.71
82627		<1%	123	$753.63
86431		<1%	552	$744.72
86800		<1%	215	$736.69
87640		<1%	62	$699.33
85240		<1%	103	$677.86
90661		<1%	43	$661.96
83605		<1%	4,200	$657.76
J1644	Injection, heparin sodium, per 1000 units	<1%	2,739	$643.94
80320		<1%	1,551	$618.62
85044		<1%	752	$607.05
86147		<1%	35	$583.18
0154A		<1%	13	$582.79
82103		<1%	117	$535.09
84132		<1%	2,317	$521.87
0012A		<1%	13	$480.00
J1815	Injection, insulin, per 5 units	<1%	766	$460.75
86355		<1%	69	$446.71
82310		<1%	875	$442.43
86200		<1%	97	$402.10
J3471	Injection, hyaluronidase, ovine, preservative free, per 1 usp unit (up to 999 usp units)	<1%	13	$395.79
72040		<1%	13	$391.90
93356		<1%	322	$385.93
85018		<1%	1,374	$384.98
87338		<1%	44	$383.02
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	405	$376.55
82040		<1%	1,620	$360.29
76813		<1%	13	$346.23
84305		<1%	81	$342.31
83695		<1%	66	$337.21
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	<1%	204	$335.18
87205		<1%	1,520	$334.12
87660		<1%	447	$334.10
90647		<1%	85	$332.06
86357		<1%	70	$321.06
71100		<1%	213	$318.82
86160		<1%	335	$317.50
86003		<1%	334	$311.67
88300		<1%	76	$306.08
99152		<1%	1,311	$295.10
90633		<1%	188	$290.91
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	17	$290.11
84520		<1%	2,666	$288.39
82553		<1%	1,447	$286.99
J1630	Injection, haloperidol, up to 5 mg	<1%	682	$284.49
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	2,087	$271.82
99153	Mod sedat endo service >5yrs	<1%	1,159	$269.56
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	1,274	$265.72
86359		<1%	60	$260.23
80081		<1%	12	$245.30
84481		<1%	146	$240.50
83921		<1%	44	$238.64
88275		<1%	14	$230.36
86235		<1%	166	$228.45
84295		<1%	1,560	$228.08
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	13	$227.27
88312		<1%	12	$220.78
84155		<1%	1,221	$216.56
88271		<1%	15	$212.06
82435		<1%	1,470	$209.76
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	218	$207.98
73140		<1%	122	$202.36
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	2,205	$197.66
80329		<1%	262	$197.17
85306		<1%	29	$193.12
83498		<1%	13	$187.47
80074		<1%	20	$183.71
80321		<1%	526	$181.23
83519		<1%	67	$177.36
92134		<1%	252	$171.17
90723		<1%	92	$169.82
82374		<1%	777	$169.80
J1650	Injection, enoxaparin sodium, 10 mg	<1%	376	$168.64
85597		<1%	16	$157.91
84166		<1%	40	$155.70
C1751	Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis)	<1%	552	$141.89
86304		<1%	17	$138.13
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	3,318	$134.92
S0020	Injection, bupivicaine hydrochloride, 30 ml	<1%	1,512	$133.14
87088		<1%	394	$131.85
73070		<1%	45	$130.83
J2060	Injection, lorazepam, 2 mg	<1%	464	$129.64
82542		<1%	54	$127.32
82397		<1%	60	$119.35
83090		<1%	12	$118.09
82610		<1%	12	$116.69
82107		<1%	12	$115.94
90707		<1%	69	$114.15
90651		<1%	47	$105.66
82390		<1%	26	$104.80
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	1,199	$103.53
82668		<1%	12	$103.38
84145		<1%	122	$98.37
82375		<1%	1,602	$98.24
87081		<1%	372	$98.22
81015		<1%	1,135	$95.41
86317		<1%	12	$94.43
85613		<1%	25	$93.08
86701		<1%	14	$90.97
Q0163	Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen	<1%	3,192	$88.36
85670		<1%	53	$87.65
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	36	$87.56
J0692	Injection, cefepime hydrochloride, 500 mg	<1%	50	$86.14
84425		<1%	25	$83.52
87449		<1%	38	$79.46
J7644	Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram	<1%	1,299	$74.88
90734		<1%	48	$65.15
85303		<1%	13	$63.68
92060		<1%	14	$63.67
90700		<1%	81	$62.66
82985		<1%	12	$60.32
73552		<1%	67	$58.52
86707		<1%	12	$52.05
87350		<1%	12	$51.90
86696		<1%	12	$49.34
83050		<1%	1,626	$49.23
84478		<1%	12	$47.37
J1596	Injection, glycopyrrolate, 0.1 mg	<1%	325	$46.56
J3480	Injection, potassium chloride, per 2 meq	<1%	43	$37.20
90685		<1%	14	$36.78
J1836	Injection, metronidazole, 10 mg	<1%	100	$35.50
91300		<1%	3,040	$35.49
J3411	Injection, thiamine hcl, 100 mg	<1%	39	$34.21
J2272	Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg	<1%	31	$34.15
86225		<1%	37	$29.99
73060		<1%	99	$27.98
86709		<1%	12	$27.62
82785		<1%	52	$27.31
82330		<1%	285	$24.62
90648		<1%	136	$24.27
85347		<1%	443	$23.96
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	<1%	497	$22.27
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	16	$21.72
89051		<1%	334	$20.77
C9113	Injection, pantoprazole sodium, per vial	<1%	38	$18.49
S0030	Injection, metronidazole, 500 mg	<1%	218	$17.27
J0780	Injection, prochlorperazine, up to 10 mg	<1%	13	$16.78
85014		<1%	386	$16.71
J1171	Injection, hydromorphone, 0.1 mg	<1%	22	$16.56
86336		<1%	12	$15.59
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	63	$14.88
A0425	Ground mileage, per statute mile	<1%	12	$14.03
80145		<1%	24	$10.61
87210		<1%	422	$10.48
87102		<1%	14	$7.57
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	25	$6.65
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	<1%	524	$4.02
87220		<1%	14	$3.84
G9903	Patient screened for tobacco use and identified as a tobacco non-user	<1%	417	$3.70
G9902	Patient screened for tobacco use and identified as a tobacco user	<1%	438	$3.01
91312		<1%	309	$2.80
J1940	Injection, furosemide, up to 20 mg	<1%	23	$2.23
J1580	Injection, garamycin, gentamicin, up to 80 mg	<1%	56	$1.41
91307		<1%	188	$1.20
J2003	Injection, lidocaine hydrochloride, 1 mg	<1%	151	$0.98
J0688	Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg	<1%	58	$0.70
91305		<1%	59	$0.59
J2550	Injection, promethazine hcl, up to 50 mg	<1%	62	$0.44
91306		<1%	37	$0.37
G9905	Patient not screened for tobacco use	<1%	29	$0.23
91315		<1%	18	$0.18
91308		<1%	12	$0.12
91301		<1%	13	$0.12
3051F		<1%	17	$0.09
1036F		<1%	1,563	$0.03
1123F		<1%	46	$0.02
G8484	Influenza immunization was not administered, reason not given	<1%	226	$0.01
4004F		<1%	504	$0.01
90710		0%	55	$0.00
99080		0%	661	$0.00
95004	Percutaneous tests with allergenic extracts, immediate type reaction	0%	12	$0.00
G8427	Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications	0%	51	$0.00
94729		0%	171	$0.00
J2004	Injection, lidocaine hcl with epinephrine, 1 mg	0%	44	$0.00
3046F		0%	40	$0.00
92133		0%	39	$0.00
86038		0%	16	$0.00
J1598	Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to j1596, 0.1 mg	0%	155	$0.00
93226		0%	13	$0.00
C1729	Catheter, drainage	0%	15	$0.00
90473		0%	12	$0.00
87653		0%	14	$0.00
G2212	Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes)	0%	44	$0.00
90698		0%	384	$0.00
90696		0%	54	$0.00
96110	Developmental screening, with scoring and documentation, per standardized instrument	0%	240	$0.00
92567		0%	25	$0.00
95012		0%	53	$0.00
51600		0%	13	$0.00
88720		0%	60	$0.00
G8419	Bmi documented outside normal parameters, no follow-up plan documented, no reason given	0%	16	$0.00
73600		0%	14	$0.00
82270		0%	13	$0.00
3044F		0%	19	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialALBANESE, CAROLYN (VP OF PFS)

Same official

Other billing entities under ALBANESE, CAROLYN

Full network →

Provider	Location	Paid
Mount Sinai Hospital	New York, NY	$2.34M
Mount Sinai Hospital	New York, NY	$352K
Mount Sinai Hospital-Ambulance	New York, NY	$322K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.